EUROPEAN DIABETOLOGY
The Charity's objectives are specifically restricted to advance the education of the public in general (and particularly among scientists and healthcare professionals) on the subject of diabetology, in particularly by (but not limited to) the promotion of research for the public benefit in all aspects of that subject and to publish the useful results.
Financial health, per its FY2025 accounts
The accounts state that the charity generated a surplus of £226,931 for the year ended 31 August 2025, bringing total unrestricted funds to £1,741,824. The trustees have designated £450,000 of these funds as a reserve to cover approximately six months of running costs. The trustees confirm there are no material uncertainties regarding the charity's ability to continue as a going concern.
What the accounts disclose
“The Trustees examined the requirements for free reserves in November 2023 and agreed that, given the nature of the work and current outstanding decisions on expenditure, this should be approximately £450,000.” — page 3
Structured financials (annual return, FY ending 31/08/2025)
Trustees
- Professor Ewan Pearsonchair
- Dr Femke Rutters
- Emma Jane Doble
- Professor Maciej Malecki
- Professor Michele Solimena
- Professor Ruth Loos
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/08/2025 | £769k | £577k |
| 31/08/2024 | £579k | £274k |
| 31/08/2023 | £703k | £909k |
| 31/08/2022 | £644k | £470k |
| 31/08/2021 | £612k | £640k |
Common questions
Is EUROPEAN DIABETOLOGY financially healthy?
Per its FY2025 accounts: The accounts state that the charity generated a surplus of £226,931 for the year ended 31 August 2025, bringing total unrestricted funds to £1,741,824. The trustees have designated £450,000 of these funds as a reserve to cover approximately six months of running costs. The trustees confirm there are no material uncertainties regarding the charity's ability to continue as a going concern. Its FY2025 accounts were independently examined.